SNX2P2

Across TCGA pan-cancer cohorts, SNX2P2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated SNX2P2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher SNX2P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNX2P2 expression acts as an unfavorable survival marker.

BLCA, HNSC, and KIRC are the cancer types where SNX2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.116	0.575	<.001	72	view →
HNSC	OS	Tertile	II,III,IV	0.082	0.711	<.001	72	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
UCEC	OS	Tertile	All	0.646	0.879	<.001	36	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	27	view →
READ	DFS	Tertile	All	0.111	0.799	.001	18	view →
PCPG	DFS	Tertile	All	0.161	0.819	.011	9	view →
LGG	OS	Tertile	All	0.160	0.448	.036	6	view →
ESCA	OS	Tertile	II,III,IV	0.455	0.715	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

SNX2P2–BLCA (DFS)

Open the BLCA breakdown →